The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership focused on advancing biopharmaceutical manufacturing, solving industry challenges, and developing the skilled workforce to meet industry’s needs.
The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.
NIIMBL will lead and transform the development and adoption of next-generation biopharmaceutical manufacturing technologies that contribute to patient well-being. As a public–private partnership, NIIMBL will forge and catalyze advancements that are vital to the acceleration of innovative technologies and a skilled workforce, and these strategic efforts and investments will be undertaken to secure U.S. biopharmaceutical manufacturing leadership.
NIIMBL is made up of a range of stakeholders, including:
Members have the opportunity to collectively revolutionize current biomanufacturing platforms, processes, and educational programs and share in the benefits of these transformative solutions.
As of June 30, 2023
NIIMBL is a proud member of Manufacturing USA®, a network of federally sponsored manufacturing innovation institutes. NIIMBL is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.
Together with our partners from industry, academia, non-profits, and government agencies, we:
Collaborate on innovative manufacturing platforms and technologies that accelerate the development and manufacture of life-saving medicines and medical countermeasures, enhance national economic security, and support response to biothreats
Help companies de-risk the adoption and implementation of new technologies and approaches for development and manufacturing
Strengthen the U.S. economy by cultivating a world-leading biopharmaceutical workforce that meets the industry’s needs through novel training and education programs
We achieve our mission through execution of projects. To support our work, we issue three different types of solicitations:
The NIIMBL ecosystem’s collaborative efforts to accelerate innovative manufacturing technologies help to:
Promote U.S. economic development and enhanced national security
Increase the domestic biopharmaceutical industry’s global competitiveness
Bring life-saving and life-enhancing medicines and medical countermeasures to market faster
Support the development of a resilient, integrated, domestic supply chain
Meet the workforce development needs of the biopharmaceutical manufacturing ecosystem
Hear what our members have to say:
NIIMBL gives us a great platform to share pre-competitively
Narendra Bam
Senior Vice President, Medicine Development and Supply
GlaxoSmithKline
Collaborations accelerate our innovation
Andy Wirths
Senior Vice President of America Supply Region
AstraZeneca
Ensuring we’re able to educate and develop the biopharmaceutical manufacturing workforce right here in the U.S.
David Elkins
Executive Vice President and Chief Financial Officer
Bristol Myers Squibb™
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
Executive Director
Director, Business Operations
Director, Sponsored Programs
Institute Director
Director, Business Development
NIIMBL’s national meeting is an exclusive member-only event offering inspiring plenaries, engaging sessions, and thought-provoking conversations. It affords NIIMBL membership the opportunity to both celebrate our accomplishments and plan for the future.
Feedback from the National Meeting:
